EUVIMEDEUVIMED entdecken
Crossref

Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures

Iva Neupane iD, Brian Mikolasko, Charles A Adams, Joao Filipe Goncalves Monteiro, Nadia Mujahid iD, Linda Girouard, Jessica Arabi iD, Ashna Rajan iD, Audrea Bose iD, Stephanie Lueckel, Lynn McNicoll, Stefan Gravenstein

Journal of the American Geriatrics Society · 2026-06 · 74 (6) · 1647-1657

DOI: 10.1111/jgs.70444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 16.04.2026. Verfasst von Iva Neupane und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Buprenorphine, Rib Fractures, Analgesics, Opioid, Pain Management. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Older trauma patients with rib fractures experience significantly higher morbidity and mortality compared to younger individuals. As effective pain control is a foundation of management, older adults present a challenge for clinicians aiming to balance pain control with adverse event risk. Despite the growing utilization of transdermal buprenorphine for acute pain, its effectiveness specifically in older patients with rib fractures remains under explored.

Methods

This retrospective cohort study at a trauma intensive care unit within a Level I trauma center, examined 779 patients aged ≥ 65 years admitted with multiple rib fractures from December 1, 2022 to November 30, 2024. Outcomes were compared between those who received transdermal buprenorphine and those who did not. Primary outcome was oral morphine equivalent consumption. Secondary outcomes included non‐opioid analgesic use, naloxone administration, hospital length of stay (LOS), intensive care unit (ICU) LOS, complications, discharge disposition, in‐hospital mortality, and 30‐day readmission rates.

Results

Seven hundred and eighteen admissions met inclusion criteria, with 16.4% (118) receiving transdermal buprenorphine. They were significantly older (82.0 ± 8.2 vs. 79.5 ± 8.9 years, p = 0.0054) and presented with higher comorbidities (CCI 7.3 ± 4.1 vs. 6.3 ± 3.7; p = 0.0064). Total hospital opioid use did not differ significantly. However, second day post administration opioid requirements were significantly lower in the transdermal buprenorphine group (6.5 ± 17.6 mg vs. 14.8 ± 24.9 mg, adjusted p = 0.0359), as well as overall opioid consumption after patch application (18.1 ± 46.5 mg vs. 73.8 ± 138.5 mg; adjusted p < 0.0001). No differences were observed on days three or four. We report no naloxone use in the transdermal buprenorphine group versus 1.1% in the non‐transdermal buprenorphine group. There were no significant differences in other secondary outcomes.

Conclusion

Older trauma patients with multiple rib fractures treated with transdermal buprenorphine used less opioids and less naloxone during acute pain management without other benefits including LOS and mortality, suggesting a favorable safety and analgesic profile. However, a formal evaluation through a randomized controlled trial is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineRib FracturesAnalgesics, OpioidPain ManagementAcute PainHumansRetrospective StudiesFemaleAgedAdministration, CutaneousMaleAged, 80 and overLength of StayIntensive Care Units

Stichwörter der Autor:innen

mortalityopioid analgesicspain managementrespiratory depression

Substanzen

BuprenorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Department of Trauma and Surgical Critical Care, Hackensack University Medical Center, Hackensack, New Jersey, USA.
  • Department of Surgery, The Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Department of Pharmacy, Brown University Health, Providence, Rhode Island, USA.
  • Department of Hospital Medicine, Internal Medicine, University of Kentucky, Lexington, Kentucky, USA.
  • Center of Innovation in Long-Term Services and Supports, Providence Veterans Administration Medical Center, Providence, Rhode Island, USA.

ORCID-Profile: Iva Neupane, Nadia Mujahid, Jessica Arabi, Ashna Rajan, Audrea Bose

Zitieren

APA

Neupane, I., Mikolasko, B., Adams, C. A., Monteiro, J. F. G., Mujahid, N., Girouard, L., Arabi, J., Rajan, A., Bose, A., Lueckel, S., McNicoll, L., & Gravenstein, S. (2026). Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures. Journal of the American Geriatrics Society, 74(6), 1647-1657. https://doi.org/10.1111/jgs.70444

Vancouver

Neupane I, Mikolasko B, Adams CA, Monteiro JFG, Mujahid N, Girouard L, et al. Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures. Journal of the American Geriatrics Society. 2026;74(6):1647-1657. doi:10.1111/jgs.70444

BibTeX
@article{Neupane2026,
  author = {Neupane, Iva and Mikolasko, Brian and Adams, Charles A and Monteiro, Joao Filipe Goncalves and Mujahid, Nadia and Girouard, Linda and Arabi, Jessica and Rajan, Ashna and Bose, Audrea and Lueckel, Stephanie and McNicoll, Lynn and Gravenstein, Stefan},
  title = {Transdermal Buprenorphine for Pain Management in Older Patients With Multiple Rib Fractures},
  journal = {Journal of the American Geriatrics Society},
  year = {2026},
  volume = {74},
  number = {6},
  pages = {1647--1657},
  doi = {10.1111/jgs.70444}
}
Kostenlos starten →